Related Experiment Video

Updated: Jun 2, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

Children on phenobarbital monotherapy requires more sedatives during MRI

Hatice Evren Eker1, Oya Yalcin Cok, Anis Aribogan

  • 1Department of Anesthesiology, Baskent University School of Medicine, Ankara, Turkey. evreneker@yahoo.com

Paediatric Anaesthesia
|May 14, 2011
PubMed

Insights

Epileptic children on phenobarbital monotherapy required less additional sedation during MRI. This suggests tailored anesthetic titration is needed for these patients.

Area of Science:

  • Anesthesiology
  • Pediatric Neurology
  • Pharmacology

Background:

  • Phenobarbital is known to induce hepatic cytochrome P-450 enzymes, affecting drug metabolism.
  • This induction can alter the clearance of concurrently administered medications, including anesthetics.
  • Understanding these effects is crucial for optimizing sedation in pediatric patients undergoing procedures.

Purpose of the Study:

  • To compare the duration and additional anesthetic requirements during Magnetic Resonance Imaging (MRI) in epileptic children receiving phenobarbital monotherapy versus those not on anti-epileptic drugs.
  • To evaluate the impact of phenobarbital on the sedative response to midazolam, ketamine, and propofol.
  • To inform anesthetic management strategies for epileptic children undergoing MRI.

Main Methods:

  • A study included 128 epileptic children (1-10 years) categorized into two groups: no anti-epileptic therapy (Group I) and phenobarbital monotherapy (Group II).
  • Initial sedation involved midazolam and ketamine, with additional ketamine administered as needed.
  • Rescue propofol was used to maintain sedation, and the duration and consumption of sedatives were recorded.

Main Results:

  • Children on phenobarbital monotherapy (Group II) showed a significantly shorter duration of initial and subsequent sedative requirements compared to Group I (P = 0.0001, P = 0.001).
  • Group I (no phenobarbital) required significantly lower additional ketamine doses for adequate sedation (P = 0.016).
  • These findings indicate a differential response to sedative agents based on phenobarbital use.

Conclusions:

  • The variable response to initial sedative agents in epileptic children undergoing MRI necessitates careful titration of additional sedation, particularly ketamine, in those on phenobarbital monotherapy.
  • This study highlights the importance of considering pre-existing anti-epileptic drug regimens in anesthetic planning.
  • Further research may explore specific dosage adjustments for sedatives in this patient population.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...